Graft

(redirected from Bone graft)
Also found in: Dictionary, Thesaurus, Medical, Legal, Encyclopedia.

Graft

An informal term for bribery.
References in periodicals archive ?
US-based orthobiologics company Cerapedics has received CE Mark in Europe and Therapeutic Goods Administration listing in Australia for the new i-Factor Flex FR biologic bone graft, the company said on Wednesday.
4 October 2010 - US orthobiologics and biosurgery company Orthovita Inc (NASDAQ: VITA) said today it has received US Food and Drug Administration (FDA) 510(k) clearance to market VITOMATRIX Bone Graft Substitute as a bone grafting material in certain dental procedures.
In 2010, the total Asia-Pacific markets for dental bone graft substitutes and other biomaterials grew by 3.
Keywords: Japan, south korea, australia, Dental Bone Graft Substitute, Autografts, Allografts, De-mineralized Bone Matrix (DBM) Allografts, Xenografts, Synthetics, Tissue Engineering Products, Dental Membranes
The objective of the study was to evaluate the safety and efficacy of Cerapedics' novel i-FACTOR biologic bone graft compared to autologous bone delivered via interbody fusion cages in single- and multi-level PLIF surgery.
In 2010, the total European markets for dental bone graft substitutes and other biomaterials grew by 4.
The NovaBone MIS Delivery System improves conventional delivery methods of bone graft substitutes through a syringe pre-loaded with ready-to-use NovaBone Putty and 6mm diameter cannulas at varying lengths.
The bone in the defect was significantly stiffer (stronger) at 3 months (69%) in the StronBone bone graft than in the control (it took 6 months for the control to achieve a comparable stiffness); and,
M2 EQUITYBITES-March 15, 2018-Cerapedics wins US FDA's regulatory approval to begin new IDE study of P-15L Bone Graft in TLIF procedures
M2 PHARMA-March 15, 2018-Cerapedics wins US FDA's regulatory approval to begin new IDE study of P-15L Bone Graft in TLIF procedures